Inan Ihsan, De Sousa Sandra, Myers Patrick O, Bouclier Brigitte, Dietrich Pierre-Yves, Hagen Monica E, Morel Philippe
Visceral Surgery Division, Department of Surgery, Geneva University Hospital, Rue Micheli-du-Crest 24, CH-1211, Geneva, Switzerland.
World J Surg Oncol. 2008 Aug 18;6:85. doi: 10.1186/1477-7819-6-85.
Pleural or peritoneal effusions (ascites) are frequent in terminal stage malignancies. Medical management may be hazardous.
A 60-year-old man with metastatic malignant melanoma presented refractory ascites as well as bilateral pleural effusions. After failure of the medical treatment, bilateral pleural aspiration and paracentesis became necessary two to three times a week. A multi perforated 15F silicone catheter connected with a subcutaneous port was implanted in peritoneal and both pleural cavities surgically under general anesthesia. Leakage around the catheter is prevented by subcutaneous tunneling. Surgical technique is described and illustrated in a video.
Implanted systems were immediately operational. Follow up period was 41 days. Each port was accessed 10 times and a total of 65'200 ml of fluid was drained. By the end of the forth week, pleural effusions diminished, systems were controlled for permeability and chest x-rays confirmed absence of effusion.
Implanted port systems for refractory ascites and pleural effusions avoid morbidity and the patient's anxiety related to repeated puncture-aspiration. Large catheter diameter allows an easy and fast drainage of large volumes. Compared to chronic indwelling catheters, subcutaneous location of port system allows an entire integration, giving the patient a total liberty in daily life between two sessions of drainage. Drainage can be performed in an outpatient basis as an ambulatory procedure. This patient-friendly technique may be a treatment option in case of failure of other techniques.
恶性肿瘤终末期常出现胸腔或腹腔积液(腹水)。药物治疗可能存在风险。
一名60岁转移性恶性黑色素瘤男性患者出现难治性腹水及双侧胸腔积液。药物治疗失败后,每周需进行两到三次双侧胸腔穿刺抽液及腹腔穿刺放液。在全身麻醉下,通过手术将一根与皮下端口相连的多孔15F硅胶导管植入腹腔及双侧胸腔。通过皮下隧道防止导管周围渗漏。手术技术在一段视频中进行了描述和展示。
植入系统立即投入使用。随访期为41天。每个端口使用了10次,共引流65200毫升液体。到第四周结束时,胸腔积液减少,对系统的通畅性进行了检查,胸部X光证实无积液。
用于难治性腹水和胸腔积液的植入式端口系统可避免与反复穿刺抽液相关的发病率及患者焦虑。较大的导管直径便于快速大量引流。与慢性留置导管相比,端口系统的皮下位置使其能够完全融入,使患者在两次引流之间的日常生活中完全自由。引流可作为门诊操作在门诊进行。这种对患者友好的技术在其他技术失败时可能是一种治疗选择。